Al Hammadi Holding’s net profit declined to SAR 187.8 million in 9M 2025, compared to SAR 261 million in the year-earlier period.
| Item | 9m 2024 | 9m 2025 | Change |
|---|---|---|---|
| Revenues | 831.09 | 895.03 | 7.7 % |
| Gross Income | 272.85 | 272.53 | (0.1 %) |
| Operating Income | 286.99 | 194.94 | (32.1 %) |
| Net Income | 261.04 | 187.78 | (28.1 %) |
| Average Shares | 160.00 | 160.00 | - |
| Earnings Per Share before unusual items (Riyals) | 1.29 | 1.17 | (8.7 %) |
| EPS (Riyal) | 1.63 | 1.17 | (28.1 %) |
The company attributed the decline in profits mainly to the absence of last year’s non-recurring gain of SAR 55.27 million from the sale of land, in addition to higher general and administrative as well as selling and marketing expenses.
The increase in expected credit loss provisions due to delayed collections from major customers, along with lower other income, also contributed to the result.
This came despite stable gross profits at SAR 272.53 million, supported by a 7.7% rise in revenue, driven by improved medical services contracts and higher pharmaceutical segment revenue.
| Item | Q3 2024 | Q3 2025 | Change |
|---|---|---|---|
| Revenues | 290.59 | 294.91 | 1.5 % |
| Gross Income | 96.05 | 83.03 | (13.6 %) |
| Operating Income | 81.92 | 54.33 | (33.7 %) |
| Net Income | 79.13 | 51.89 | (34.4 %) |
| Average Shares | 160.00 | 160.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.49 | 0.32 | (34.4 %) |
| EPS (Riyal) | 0.49 | 0.32 | (34.4 %) |
| Item | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Revenues | 298.24 | 294.91 | (1.1 %) |
| Gross Income | 92.99 | 83.03 | (10.7 %) |
| Operating Income | 63.89 | 54.33 | (15.0 %) |
| Net Income | 61.96 | 51.89 | (16.3 %) |
| Average Shares | 160.00 | 160.00 | - |
| Earnings Per Share before unusual items (Riyal) | 0.39 | 0.32 | (16.3 %) |
| EPS (Riyal) | 0.39 | 0.32 | (16.3 %) |
Q3 2025 net earnings declined 34.4% to SAR 51.89 million, compared to SAR 79.13 million in Q3 2024.
Sequentially, the company’s net profit declined 16.3% from SAR 61.96 million.
Total shareholders’ equity, no minority interest, advanced to SAR 1.98 billion by Sept. 30, 2025, compared to SAR 1.93 billion in a prior-year period.
| Company | Estimated | Actual | Change |
|---|---|---|---|
| TASNEE | (10.58) | (558.50) | |
| TANMIAH | 1.10 | (15.80) | |
| MAHARAH | 41.40 | 44.46 | |
| ALHAMMADI | 72.42 | 51.89 | |
| JAHEZ | 51.00 | 62.60 | |
| RETAL | 64.00 | 55.75 | |
| AWPT | 67.00 | 69.59 | |
| ENTAJ | 4.35 | 0.10 | |
| CATRION | 79.07 | 97.02 | |
| TCC | 14.50 | 8.25 |
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: